Peter Ashley Marks insider trades: Alterity Therapeutics (ATHE) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | ATHE | ↑ Buy | 47,620 | $0.50 | $24K | Lampam Pty Ltd | Sep 8, 2026 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Peter Ashley Marks's insider trades
Peter Ashley Marks is a director at Alterity Therapeutics (ATHE). Since Aug 31, 2026, Peter has reported 1 open-market purchase worth $24K and no sales on SEC Form 4. In the last 12 months: 1 buy ($24K).
Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATHE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.